(TSVT) stock lost as company with Bristol Myers Squibb (BMY) plan to discontinue enrollments in a Phase 3 trial for cancer ...

Laura Foran's late husband, Gerry, had a desk plaque that said, "I'm kind of a big deal." The 47-year-old Allentown woman is ...

Bristol Myers Squibb Employees to Relay Nearly 3,000 Miles Cross-Country Aspiring to Raise Over $1 Million for the V ...

There was a lot to cheer outside Enterprise Center Tuesday morning. Riders ready to brave their bikes with the St. Louis ...

Radiant Biotherapeutics, whose labs are located in Toronto, aims to use the financing to pursue its signature technology, an ...

BMO Capital analyst Evan Seigerman maintained a Hold rating on Bristol-Myers Squibb (BMY – Research Report) today and set a price target ...

Bristol Myers Squibb Co. closed $10.05 below its 52-week high ($59.46), which the company reached on September 22nd.

In the assessment of 12-month price targets, analysts unveil insights for Bristol-Myers Squibb, presenting an average target ...

The hits just keep on coming for Bristol Myers Squibb staffers amid the company's cost-savings program.  | Bristol Myers ...

In a report released today, Srikripa Devarakonda from Truist Financial maintained a Buy rating on Bristol-Myers Squibb (BMY – Research ...

Two specialists are impressed by the preliminary findings of a randomized trial in newly diagnosed patients, but another is ...